401 TAS-121, a highly potent and mutant-specific EGFR inhibitor, overcomes T790M-acquired resistance with promising antitumor activity through specific inhibition of mutant EGFR signaling
Year: 2014
Type: article
Source: European Journal of Cancer
Authors: M. Kato, K. Miyadera, K. Ito, Y. Aoyagi, A. Hashimoto, K. Yonekura, Y. Iwasawa, T. Utsugi
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2000720394